Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis

Masaki Shimizu, Mao Mizuta, Takahiro Yasumi, Naomi Iwata, Yuka Okura, Noriko Kinjo, Hiroaki Umebayashi, Tomohiro Kubota, Yasuo Nakagishi, Kenichi Nishimura, Masato Yashiro, Junko Yasumura, Kazuko Yamazaki, Hiroyuki Wakiguchi, Nami Okamoto, Masaaki Mori

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To validate whether the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA) is practical in the real world. Methods: A combination of expert consensus and analysis of real patient data was conducted by a panel of 15 pediatric rheumatologists. A total of 65 profiles comprised 18 patients with systemic JIA-associated MAS and 47 patients with active systemic JIA without evidence of MAS. From these profiles, 10 patient data points for full-blown MAS, 11 patient data points for MAS onset, and 47 patient data points for acute systemic JIA without MAS were evaluated. Results: Evaluation of the classification criteria to discriminate full-blown MAS from acute systemic JIA without MAS showed a sensitivity of 1.000 and specificity of 1.000 at the time of full-blown MAS. Sensitivity was 0.636 and specificity was 1.000 at the time of MAS onset. The number of measurement items that fulfilled the criteria increased in full-blown MAS compared to that at MAS onset. At MAS onset, the positive rates of patients who met the criteria for platelet counts and triglycerides were low, whereas those for aspartate aminotransferase were relatively high. At full-blown MAS, the number of patients who met the criteria for each measurement item increased. Conclusion: The classification criteria for MAS complicating systemic JIA had a very high diagnostic performance. However, the diagnostic sensitivity for MAS onset was relatively low. For the early diagnosis of MAS in systemic JIA, the dynamics of laboratory values during the course of MAS should be further investigated.

Original languageEnglish
JournalArthritis Care and Research
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Macrophage Activation Syndrome
Juvenile Arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis. / Shimizu, Masaki; Mizuta, Mao; Yasumi, Takahiro; Iwata, Naomi; Okura, Yuka; Kinjo, Noriko; Umebayashi, Hiroaki; Kubota, Tomohiro; Nakagishi, Yasuo; Nishimura, Kenichi; Yashiro, Masato; Yasumura, Junko; Yamazaki, Kazuko; Wakiguchi, Hiroyuki; Okamoto, Nami; Mori, Masaaki.

In: Arthritis Care and Research, 01.01.2018.

Research output: Contribution to journalArticle

Shimizu, M, Mizuta, M, Yasumi, T, Iwata, N, Okura, Y, Kinjo, N, Umebayashi, H, Kubota, T, Nakagishi, Y, Nishimura, K, Yashiro, M, Yasumura, J, Yamazaki, K, Wakiguchi, H, Okamoto, N & Mori, M 2018, 'Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis', Arthritis Care and Research. https://doi.org/10.1002/acr.23482
Shimizu, Masaki ; Mizuta, Mao ; Yasumi, Takahiro ; Iwata, Naomi ; Okura, Yuka ; Kinjo, Noriko ; Umebayashi, Hiroaki ; Kubota, Tomohiro ; Nakagishi, Yasuo ; Nishimura, Kenichi ; Yashiro, Masato ; Yasumura, Junko ; Yamazaki, Kazuko ; Wakiguchi, Hiroyuki ; Okamoto, Nami ; Mori, Masaaki. / Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis. In: Arthritis Care and Research. 2018.
@article{3db2871f49c440f68a23194656a228e5,
title = "Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis",
abstract = "Objective: To validate whether the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA) is practical in the real world. Methods: A combination of expert consensus and analysis of real patient data was conducted by a panel of 15 pediatric rheumatologists. A total of 65 profiles comprised 18 patients with systemic JIA-associated MAS and 47 patients with active systemic JIA without evidence of MAS. From these profiles, 10 patient data points for full-blown MAS, 11 patient data points for MAS onset, and 47 patient data points for acute systemic JIA without MAS were evaluated. Results: Evaluation of the classification criteria to discriminate full-blown MAS from acute systemic JIA without MAS showed a sensitivity of 1.000 and specificity of 1.000 at the time of full-blown MAS. Sensitivity was 0.636 and specificity was 1.000 at the time of MAS onset. The number of measurement items that fulfilled the criteria increased in full-blown MAS compared to that at MAS onset. At MAS onset, the positive rates of patients who met the criteria for platelet counts and triglycerides were low, whereas those for aspartate aminotransferase were relatively high. At full-blown MAS, the number of patients who met the criteria for each measurement item increased. Conclusion: The classification criteria for MAS complicating systemic JIA had a very high diagnostic performance. However, the diagnostic sensitivity for MAS onset was relatively low. For the early diagnosis of MAS in systemic JIA, the dynamics of laboratory values during the course of MAS should be further investigated.",
author = "Masaki Shimizu and Mao Mizuta and Takahiro Yasumi and Naomi Iwata and Yuka Okura and Noriko Kinjo and Hiroaki Umebayashi and Tomohiro Kubota and Yasuo Nakagishi and Kenichi Nishimura and Masato Yashiro and Junko Yasumura and Kazuko Yamazaki and Hiroyuki Wakiguchi and Nami Okamoto and Masaaki Mori",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/acr.23482",
language = "English",
journal = "Arthritis Care and Research",
issn = "2151-464X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis

AU - Shimizu, Masaki

AU - Mizuta, Mao

AU - Yasumi, Takahiro

AU - Iwata, Naomi

AU - Okura, Yuka

AU - Kinjo, Noriko

AU - Umebayashi, Hiroaki

AU - Kubota, Tomohiro

AU - Nakagishi, Yasuo

AU - Nishimura, Kenichi

AU - Yashiro, Masato

AU - Yasumura, Junko

AU - Yamazaki, Kazuko

AU - Wakiguchi, Hiroyuki

AU - Okamoto, Nami

AU - Mori, Masaaki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: To validate whether the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA) is practical in the real world. Methods: A combination of expert consensus and analysis of real patient data was conducted by a panel of 15 pediatric rheumatologists. A total of 65 profiles comprised 18 patients with systemic JIA-associated MAS and 47 patients with active systemic JIA without evidence of MAS. From these profiles, 10 patient data points for full-blown MAS, 11 patient data points for MAS onset, and 47 patient data points for acute systemic JIA without MAS were evaluated. Results: Evaluation of the classification criteria to discriminate full-blown MAS from acute systemic JIA without MAS showed a sensitivity of 1.000 and specificity of 1.000 at the time of full-blown MAS. Sensitivity was 0.636 and specificity was 1.000 at the time of MAS onset. The number of measurement items that fulfilled the criteria increased in full-blown MAS compared to that at MAS onset. At MAS onset, the positive rates of patients who met the criteria for platelet counts and triglycerides were low, whereas those for aspartate aminotransferase were relatively high. At full-blown MAS, the number of patients who met the criteria for each measurement item increased. Conclusion: The classification criteria for MAS complicating systemic JIA had a very high diagnostic performance. However, the diagnostic sensitivity for MAS onset was relatively low. For the early diagnosis of MAS in systemic JIA, the dynamics of laboratory values during the course of MAS should be further investigated.

AB - Objective: To validate whether the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA) is practical in the real world. Methods: A combination of expert consensus and analysis of real patient data was conducted by a panel of 15 pediatric rheumatologists. A total of 65 profiles comprised 18 patients with systemic JIA-associated MAS and 47 patients with active systemic JIA without evidence of MAS. From these profiles, 10 patient data points for full-blown MAS, 11 patient data points for MAS onset, and 47 patient data points for acute systemic JIA without MAS were evaluated. Results: Evaluation of the classification criteria to discriminate full-blown MAS from acute systemic JIA without MAS showed a sensitivity of 1.000 and specificity of 1.000 at the time of full-blown MAS. Sensitivity was 0.636 and specificity was 1.000 at the time of MAS onset. The number of measurement items that fulfilled the criteria increased in full-blown MAS compared to that at MAS onset. At MAS onset, the positive rates of patients who met the criteria for platelet counts and triglycerides were low, whereas those for aspartate aminotransferase were relatively high. At full-blown MAS, the number of patients who met the criteria for each measurement item increased. Conclusion: The classification criteria for MAS complicating systemic JIA had a very high diagnostic performance. However, the diagnostic sensitivity for MAS onset was relatively low. For the early diagnosis of MAS in systemic JIA, the dynamics of laboratory values during the course of MAS should be further investigated.

UR - http://www.scopus.com/inward/record.url?scp=85050452552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050452552&partnerID=8YFLogxK

U2 - 10.1002/acr.23482

DO - 10.1002/acr.23482

M3 - Article

C2 - 29195002

AN - SCOPUS:85050452552

JO - Arthritis Care and Research

JF - Arthritis Care and Research

SN - 2151-464X

ER -